CJC-1295 (NO DAC)

CJC-1295 (NO DAC) is a synthetic modified peptide compound designed for laboratory research. This molecular variant lacks the Drug Affinity Complex (DAC) modification, resulting in different stability characteristics in experimental conditions. The compound features a precisely engineered 29-amino acid sequence structure, showing selective receptor binding properties in vitro studies. Without the DAC modification, this variant demonstrates different pharmacokinetic properties in solution compared to its DAC-modified counterpart, making it particularly suitable for specific types of acute laboratory studies and molecular signaling research.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.